Di Biase, Stefano <br/><br/>
Fasting regulates EGR1 and protects from glucose- and dexamethasone-dependent sensitization to chemotherapy.  [electronic resource] 

 -  PLoS biology  03 2017 
 - e2001951 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1545-7885 
<br/><br/><label>Standard No.: </label>10.1371/journal.pbio.2001951  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinases--metabolism<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Atrial Natriuretic Factor--metabolism<br/>Cardiotoxins--toxicity<br/>Cyclic AMP-Dependent Protein Kinases--metabolism<br/>Cytoprotection--drug effects<br/>Dexamethasone--pharmacology<br/>Diet<br/>Early Growth Response Protein 1--metabolism<br/>Fasting--metabolism<br/>Female<br/>Glucose--pharmacology<br/>Hyperglycemia--pathology<br/>Metformin--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Natriuretic Peptide, Brain--metabolism<br/>Stress, Physiological--drug effects<br/>Time Factors